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ABSTRACT
Objectives Timely access to outpatient services is a 
major issue for public health systems. To address this 
issue, we aimed to establish the return on investment to 
the health system of the implementation of an alternative 
model for access and triage (Specific Timely Appointments 
for Triage: STAT) compared with a traditional waitlist 
model.
Design Using a prospective pre–post design, an economic 
analysis was completed comparing the health system 
costs for participants who were referred for community 
outpatient services post- implementation of STAT with a 
traditional waitlist comparison group.
Setting Eight community outpatient services of a health 
network in Melbourne, Australia.
Participants Adults and children referred to community 
outpatient services.
Interventions STAT combined targeted activities to 
reduce the existing waiting list and direct booking of 
patients into protected assessment appointments. STAT 
was compared with usual care, in which new patients 
were placed on a waiting list and offered appointments as 
space became available.
Outcomes Health system costs included STAT 
implementation costs, outpatient health service use, 
emergency department presentations and hospital 
admissions 3 months before and after initial outpatient 
appointment. Waiting time was the primary outcome. 
Incremental cost- effectiveness ratios (ICERs) were 
estimated from the health system perspective.
Results Data from 557 participants showed a 16.9 days 
or 29% (p<0.001) reduction in waiting time for first 
appointment with STAT compared with traditional waitlist. 
The ICER showed a cost of $A10 (95% CI −19 to 39) per 
day reduction in waiting time with STAT compared with 
traditional waitlist. Modelling showed the cost reduced to 
$A4 (95% CI −25 to 32) per day of reduction in waiting, if 
reduction in waiting times is sustained for 12 months.
Conclusions There was a significant reduction in waiting 
time with the introduction of STAT at minimal cost to the 
health system.
Trial registration number Australian New Zealand 
Clinical Trials Registry (ACTRN12615001016527).
INTRODUCTION
Prolonged waiting times present a challenge 
for community- based public health services 
and the patients who seek these services.1–4 
Delays in care are the result of a discrep-
ancy between demand for a service and the 
capacity of the service to meet this demand.5 
Lack of capacity may reflect insufficient 
resources to provide the necessary services, 
but can also be due to suboptimal use of 
available resources.6 7 When this discrep-
ancy is not addressed, queues or waiting lists 
are formed.8 Where waiting lists continue 
to grow, this is likely to indicate an ongoing 
imbalance between supply and demand. 
However, if there is a short- term disruption 
to supply, a waiting list might develop that 
becomes stable over time, suggesting that 
supply and demand may be balanced but with 
the response to new referrals always weeks or 
months behind. These queues delay access to 
community- based services with detrimental 
effects on patient outcomes including phys-
ical, psychological health and well- being, with 
associated economic costs.9–13
Two common approaches to managing 
waiting lists are short- term increases in 
supply to reduce the waiting list and imple-
mentation of triage and prioritisation 
systems to sort patients according to their 
urgency of care.7 14 Temporary increases in 
supply without ongoing changes to service 
Strengths and limitations of this study
 ► Economic evaluation of an alternative model for ac-
cess and triage (Specific Timely Appointments for 
Triage) that has reduced waiting times for commu-
nity outpatient services.
 ► Economic evaluation nested within a larger stepped- 
wedge randomised controlled trial with participants 
blind to intervention.
 ► Study conducted across a diversity of publicly fund-
ed community outpatient services increasing the 
generalisability of the findings.
 ► Limited to economic evaluation from a health ser-
vice perspective.
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delivery only resolve the issue in the short term; ineffi-
cient processes, lack of protected appointments for new 
patients and temporary disruptions to supply mean that 
waiting lists soon reappear.7 Triage systems may ensure 
that urgent patients have access to care, but make limited 
difference to waiting times overall and those classified as 
‘low priority’ in triage systems may never receive care.14 
Neither of these strategies address the discrepancy 
between supply and demand over the long term.15
Models that actively address both the existing waiting 
list and the suboptimal use of resources for ongoing 
care have had success in reducing waiting times.16 17 The 
Specific Timely Appointments for Triage (STAT) model is 
one example, which reduced waiting time by 34% across 
eight community outpatient services in a stepped- wedge 
cluster randomised controlled trial.17 The fundamental 
principle of STAT is that the rate of demand is calcu-
lated, and the number of new appointments required 
each week to keep up with demand is protected in clini-
cian schedules. This is complemented by a short- term, 
targeted intervention to reduce or clear the backlog of 
waiting patients prior to the introduction of protected 
appointments for new patients. These processes reduce 
waiting times by ensuring that there is a balance between 
supply and demand. The STAT model is different from 
open or advanced access models that leave appoint-
ments open for new patients in that all appointments 
are scheduled,18 with new patients receiving a scheduled 
appointment when their referral is received. The STAT 
model addresses identified weaknesses of the open access 
models, especially concerns related to lack of continuity 
of care.18
While STAT has been demonstrated to be effective 
in reducing waiting time across a variety of community 
outpatient services,17 policymakers need information 
about the cost implications of the model in order to make 
informed decisions about the return on investment of 
implementation from a health system perspective. STAT 
does not require any ongoing resources, but there are 
short- term implementation costs involved in reducing 
the existing backlog. It is unknown if the investment in 
resources to reduce the backlog of waiting patients is 
offset by savings in the community outpatient episode of 
care. A further complexity in evaluating the costs of the 
STAT model is that the costs of implementation occur 
as an upfront investment but the benefits are realised by 
patients who attend the service in the future, through 
reduced waiting time impacting on health and well- being. 
Return on investment is, therefore, determined not just 
from the immediate impact on the health service but by 
the number of patients who subsequently benefit. This 
in turn is dependent on the amount of time after the 
initial investment that reductions in waiting time can be 
sustained.
We aimed to complete cost- effectiveness analyses, 
using data from two cohorts of patients who attended the 
participating services before and after the introduction 
of the STAT model. The primary aim was to determine, 
from a health system perspective, the return on invest-
ment of implementing the STAT model, compared 
with a traditional model of access and triage. Sustain-




A prospective pre–post economic study was nested within 
a larger stepped- wedge cluster randomised controlled 
trial.16 17 Routinely collected data informed the analysis of 
the larger trial while the economic component involved 
intensive patient- level data collection. As such, it was not 
possible to collect economic data from all patients who 
participated in the larger stepped- wedge trial, instead 
economic data were collected from a sample of patients 
at each site. These data were collected from outpatients 
who received an initial appointment when a traditional 
waitlist and triage model operated, and an independent 
cohort who commenced care within 9 months post- STAT 
implementation.
The trial, including this nested pre–post economic 
study, was registered prospectively with the Australian and 
New Zealand Clinical Trials Registry and the report has 
been prepared with reference to the Consolidated Health 
Economic Evaluation Reporting Standards checklist.19
Patient involvement
Patients were involved in the conduct of this research. 
During the trial, a patient joined the independent trial 
steering committee. Once the trial has been published, 
participants will be informed of the results through a 
research group’s website ( www. stat. trekeducation. org).
Setting
Eight community outpatient services of a public health 
network providing care to a population of more than 
700 000 people in eastern Melbourne, Australia, that 
extended into adjacent rural communities, participated. 
The community outpatient sites all offered allied health, 
medical and/or nursing therapy services (most within 
multidisciplinary teams); provided care over a series of 
appointments; prior to the implementation of STAT had 
used waiting lists with triage systems to manage demand; 
and had stable waiting lists over the previous 2 years. 
Services meeting these criteria were selected from 28 
community outpatient services within the network that 
participated in a preliminary study exploring percep-
tions of factors that affect waiting lists.4 The eight services 
provided the following specialty clinical services: conti-
nence (n=2), movement disorders (n=1), developmental 
disorders (n=1) and mixed (orthopaedics/neurological/
general frailty) (n=4). They included a mixture of single 
discipline (n=3) and multidisciplinary (n=5) services, and 
provided healthcare to paediatric (n=3), adult (n=4) and 
mixed (n=1) populations.17
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Patients and recruitment
Between October 2015 and June 2017, outpatients 
attending their first outpatient visit were recruited from 
the eight services. Potential participants were approached 
consecutively to provide economic and quality of life data 
during their first clinic visit. Recruitment continued at 
each service until the target sample size was reached, 
or until the conclusion of the trial period. If unable 
to give written informed consent due to cognitive or 
communication impairments, or age (<18 years of age), 
their guardian or responsible person was approached to 
provide written consent on their behalf. Outpatients were 
blinded to whether they were attending the service within 
the traditional waitlist or STAT period.
Intervention
During the pre- STAT implementation period, all services 
used a traditional waitlist and triage system (termed 
a traditional waitlist model) to manage access, where 
outpatients who were deemed to have a ‘low’ need had 
a longer wait to access the service than outpatients who 
were deemed to have a ‘high’ need. Appointments were 
offered to new patients as they could be accommodated 
in clinician schedules. There were no systems in place to 
match supply (ie, number of appointments required for 
new patients) with demand (ie, number of new patients 
referred).
The intervention (STAT) has been described in detail 
previously.16 STAT involved the following steps:
 ► Short- term strategies to reduce the existing waiting list: partic-
ipating services were provided with small injection of 
resources to assist with reducing backlog. Services 
were permitted to use these resources in whatever 
way they deemed most effective (eg, employing addi-
tional short- term staff, contracting work to private 
providers). These resources were provided in the 
short term only (ie, 3 months) and no additional 
ongoing resources were provided. Existing patients 
who remained on the waiting list following this short- 
term reduction strategy were assigned the next avail-
able appointment, consistent with the STAT model.
 ► Demand calculated: the rate of demand and number 
of new appointments required each week to keep up 
with this demand was calculated based on historical 
data, including an allowance of additional appoint-
ments, to account for time lost due to staff leave and 
statutory holidays.
 ► Required appointments protected: the appointments 
required to keep up with demand were protected 
in clinician schedules. New patients were allocated 
to these appointments immediately after referral in 
order of arrival. Triage processes were scaled back 
or ceased and booking processes were simplified, 
although most services maintained systems for ‘emer-
gency’ appointments to accommodate very urgent 
patients if required.
 ► Prioritisation of resources in the context of demand: prior-
itisation decisions shifted from priority of access to 
the service to a focus on priority of need for ongoing 
services after the initial appointment. The treating 
clinician made a decision using clinical judgement of 
the patient’s need for ongoing services and within the 
context of the known demand for service.
Health system costs
Costs to the health system (in 2017 Australian dollars) in 
STAT and the traditional waitlist model over 6 months 
were determined from services used by the patient in 
the 3 months prior to their first appointment and the 3 
months after their first appointment.
The 3- month period prior to the first appointment 
for each participant was important because people who 
waited longer for their first appointment may have had 
a higher use of alternative services, such as visits to the 
emergency department. Three months after first appoint-
ment was important because people who waited longer 
may have subsequently required more intensive services 
to treat their condition.
A standardised questionnaire developed for the 
study was administered to participants during their first 
appointment. The health service utilisation question-
naire asked participants about the number of appoint-
ments received from other health services, the number 
of emergency department presentations and the number 
of nights admitted to hospital in the previous 3 months. 
Information from health service utilisation question-
naires was compared with participant medical records 
from the previous 3 months to check data accuracy.
Health service utilisation data in the 3 months after the 
first appointment were obtained using routinely collected 
data rather than a participant questionnaire due to prac-
tical difficulties obtaining adequate response rates from 
follow- up questionnaires. Medical records were audited 
to determine the number of appointments received from 
the participating health network, as well as the number of 
emergency department presentations and the number of 
nights admitted to hospital.
Health service use external to the participating health 
network during the 3 months prior to the first appoint-
ment was costed at consultation rates for private health 
practitioners,20 21 and the cost to the participating health 
network was costed at consultation rates for public service 
health practitioners.22 Cost of emergency department 
presentations was based on the price for non- admitted 
triage category 4.23 The cost of a hospital admission was 
calculated at a per diem rate, by dividing the average total 
cost of admission by the average length of stay (table 1).24 
Health service utilisation costs for the 3 months before 
and after the first appointment were summed for each 
outpatient to calculate the cost to the health system.
The only cost of implementing STAT was the cost 
involved in providing the initial targeted intervention 
to reduce the waiting list. The cost of implementation 
was calculated per patient at each of the eight services 
by dividing the cost of the STAT backlog reduction 
activities at each service by the total number of patients 
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commencing services during the first 3 months of STAT. 
The total number of new patients at each service was 
obtained from the larger trial.16 17
The total cost of implementing the STAT intervention 
was $A72 049 across the eight services. This equated to a 
weighted average cost of approximately $A105 per patient 
over a 3- month period, ranging from $A6 to $A358 per 
patient at individual sites. The weighted average cost 
reduced to $A52.50 or $A26.25 per patient if distributed 
over 6 months or 12 months, respectively. To calculate the 
cost of care per patient during the post- implementation 
period, the ‘per patient’ implementation cost for each 
service was added to the direct cost of the health service 
that each participant received.
The return on investment of STAT was modelled at 6 
and 12 months post- implementation with the assump-
tion that demand was constant (number of outpa-
tients referred) and the reduction in waiting time was 
sustained. Within these models, the per patient cost of 
implementing STAT was calculated for each time period 
by doubling the number of outpatients for the 6- month 
model, and multiplying by 4 for the 12- month model.
Outcome measures
The key outcome contributing to the economic analyses 
was waiting time, measured as the number of days from 
referral to first appointment.
The Assessment of Quality of Life (AQOL- 8D) instru-
ment was used to obtain a physical, mental and global 
utility score for quality of life,25 26 to provide a broad indi-
cation of the health status of participants. The AQOL- 8D 
was administered on the day of the first outpatient 
appointment. During the administration of the AQOL- 
8D, the participant was asked to reflect on the previous 
week.
Participant demographics including age, sex, informal 
care needs, receipt of government benefits, referral 
reason, referral source, health professional discipline 
conducting first appointment and discharge status at 3 
months after the initial assessment were collected from 
medical records.
Sample size
We aimed to sample 40 participants at each site during 
the traditional waitlist and STAT periods. Since cost- 
effectiveness was based on return on investment for each 
day of waiting time reduced post- STAT implementation 
compared with traditional waitlist model, sample size 
was based on waiting time. It was estimated that a sample 
of 640 participants (320 in each group) would provide 
greater than 99% power to detect a reduction in waiting 
time of one- third from a traditional waitlist model of 18 
days (SD 12) at an alpha level of 0.05.27
Table 1 Costs Included in the economic evaluation in 2017 $A
Unit Unit cost Data source
Itemised health costs (private)
General practitioner Consult $37.05 MBS; item 23
Physiotherapist Consult $52.57 TAC; item PY602R
Occupational therapist Consult $45.85 TAC; item OT0006
Other allied health Consult $45.85 TAC; item SW602, D602; F012
Nurse practitioner Consult $86.39 TAC
Itemised health costs (public health 
network)
Emergency department presentation Presentation $369 IHPA; non- admitting triage category 4
Hospital admission Day $1821.43 AIHW; Australian Hospital Statistics
Medical (movement disorders) Consult $315 IHPA; non- admitted activity category 20.15 Neurology
Medical (continence) Consult $206 IHPA; non- admitted activity category 20.36 Urology
Physiotherapist Consult $159 IHPA; non- admitted activity category 40.09 Physiotherapy
Occupational therapist Consult $174 IHPA; non- admitted activity category 40.06 Occupational 
Therapy
Dietitian Consult $209 IHPA; non- admitted activity category 40.23 Nutrition/Dietetics
Social worker Consult $212 IHPA; non- admitted activity category 40.11 Social Work
Speech pathologist Consult $209 IHPA; non- admitted activity category 40.18 Speech Pathology
Psychologist Consult $131 IHPA; non- admitted activity category 40.29 Psychology
Nurse (movement disorders) Consult $125 IHPA; non- admitted activity category 40.32 Neurology
Nurse (continence) Consult $195 IHPA; non- admitted activity category 40.39 Continence
AIHW, Australian Institute of Health and Welfare; IHPA, Independent Hospital Pricing Authority; MBS, Medicare Benefits Scheme; TAC, 
Transport Accident Commission.
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Statistical analysis
Between- group differences in waiting time and health 
system costs were calculated with analysis of covariance 
(ANCOVA) using service as a covariate to account for 
clustering. Incremental cost- effectiveness ratios (ICERs) 
represent the difference in cost between the STAT and 
traditional waitlist periods, divided by the difference in 
their effect (waiting days saved). ICERs were calculated 
from waiting time using mean differences derived from 
ANCOVA.
CIs around ICERs were calculated using the bootstrap 
method (5000 repetitions), the difference in waiting time 
between STAT and traditional waitlist, and cost from 
health system perspectives.28 Individual ICERs were used 
to generate confidence ellipses using the central limit 
theorem.28 The ellipses provide information relating to 
the statistical significance of the intervention (STAT) 
being investigated.
Patient demographics were compared using Χ2 for cate-
gorical/binary data and t- tests for continuous data.
Analyses were completed using IBM SPSS statistics 
V.24,29 and customised software in Microsoft Excel.28 
Statistical tests were conducted at 0.05 level of signifi-
cance and described using 95% CIs.
RESULTS
Economic data were collected from 557 participants; 278 
traditional waitlist participants and 279 STAT participants.
Baseline characteristics
The groups were similar for sex, age, referral reason, 
referral source, number of missed appointments, propor-
tion discharged from the health network within 3 months 
of first appointment and proportion receiving informal 
care (table 2). More traditional waitlist participants had 
their first appointment with a nurse, while more STAT 
participants had their first appointment with a medical 
practitioner. The proportion of participants receiving 
government benefits was significantly lower with STAT 
compared with traditional waitlist.
The mean (SD) AQOL- 8D global utility score was 0.71 
(0.21) in the STAT group and 0.68 (0.20) in the tradi-
tional waitlist group (mean difference 0.03, p=0.066).
The characteristics of the participating outpatient 
services can be viewed in online supplemental file 1.
Health system costs
The mean total cost was $A165 (95% CI −261 to 592, 
p=0.447) greater with STAT compared with traditional wait-
list. This cost was attributable to the cost of implementing 
STAT, as there were no differences in the cost of hospital 
admissions, emergency department attendance or outpa-
tient health professional service use. The mean cost per 
patient of implementing STAT distributed over 3 months 
of new patient admissions was $A121 (SD $91) (table 3).
Waiting time
There was a significant reduction in waiting time for STAT 
participants (mean: 40.8 days, SD: 31.3), who waited, on 
average, 16.9 days less for their first appointment than 
traditional waitlist participants (mean: 57.7 days, SD: 49.3, 
p<0.001). Weighted mean waiting time for the partic-
ipants in the 10th percentile (ie, those that waited the 
least amount of time) was 1.1 days longer in the STAT 
Table 2 Participant characteristics at baseline in traditional 
waitlist and STAT groups
Traditional 
waitlist n=278 STAT n=279
P valuen (%) n (%)
Sex (female) 155 (56) 161 (58) 0.642
Age* (years) 37 (32) 38 (32) 0.864
Referral reason 0.743
  Musculoskeletal 63 (23) 73 (26)
  Neurological 24 (9) 25 (9)
  Developmental 
assessment
101 (36) 90 (32)
  Incontinence 79 (28) 83 (30)
  General function 
(falls, mobility, home 
assessment)
11 (4) 8 (3)
Referral source† 0.325
  Hospital 36 (13) 29 (10)
  Medical practitioner 80 (29) 66 (24)
  Self/relative/carer 34 (12) 36 (13)
  Community service 
provider




  Physiotherapist 166 (60) 172 (62)
  Occupational 
therapist
14 (5) 12 (4)
  Speech pathologist 38 (14) 43 (15)
  Nurse 49 (18) 26 (9)
  Medical 6 (2) 20 (7)
  Social worker 4 (1) 4 (1)
  Dietitian 1 (<1) 2 (1)
Discharged from health 
service within 3 months 
of 1st appointment
112 (40) 97 (34) 0.178
Missed appointments* 0.27 (0.96) 0.25 (0.71) 0.76
Received government 
benefits
181 (65) 154 (55) 0.017
Received informal care 56 (20) 62 (22) 0.548




0.63 (0.24) 0.65 (0.24) 0.288
Mental dimension utility 
(276/272)
0.39 (0.19) 0.42 (0.19) 0.078
Global utility
(276/271)
0.68 (0.20) 0.71 (0.21) 0.066
*Reported as mean (SD).
†One missing data point, data calculated from 278 participants.
AQOL- 8D, Assessment of Quality of Life; STAT, Specific Timely Appointments 
for Triage.
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group (10.0 days) compared with the traditional waitlist 
group (8.9 days). Weighted mean waiting time for partic-
ipants in the 90th percentile (ie, those that waited the 
most amount of time) was 46.1 days shorter in the STAT 
group (86.0 days compared with the traditional waitlist 
group (132.1 days).
Incremental cost-effectiveness ratios
From a health system perspective, the ICER showed a 
cost of $A10 (95% CI −19 to 39) per day of reduction in 
waiting time with STAT compared with traditional wait-
list. The ICER ellipses for confidence bands of 50%, 75% 
and 95% show that all CIs are distributed between the 
lower and upper right quadrants (figure 1).30
Cost-effectiveness acceptability curve
The cost- effectiveness acceptability curve shows that there 
was a 50% probability that the additional cost of STAT, 
compared with traditional waitlist, was at or below $A10 
per day of waiting saved (figure 2).
Modelling of effect at 6 months and 12 months post-
implementation
If the costs of implementation of STAT are distributed 
over 6 months, the ICER shows a cost of $A6 (95% CI −22 
to 34) per day of reduction in waiting time (table 4). The 
curve shows a 61% probability that the additional cost of 
STAT, compared with a traditional waitlist, was at or below 
$A10 per day of waiting saved.
Table 3 Mean total cost (SD) of groups and mean (95% CI) difference between groups ($A) from a health system perspective 
at 3 months
Perspective
Groups Difference between groups
P valueTraditional waitlist n=278 STAT n=279
Mean difference
(95% CI)
Total cost 1324 (2755) 1486 (2383) 165 (−261 to 592) 0.447
12 weeks before 1st appointment 648 (2584) 635 (1962) −13 (−395 to 370) 0.949
  Hospital admission 197 (2354) 144 (1592) −52 (−387 to 282) 0.758
  Emergency department attendance 125 (226) 110 (224) −15 (−52 to 22) 0.418
  Outpatient health professional service 327 (423) 382 (968) 55 (−69 to 180) 0.384
12 weeks after 1st appointment 676 (965) 851 (1036) 178 (16 to 316) 0.031
  Hospital admission 128 (834) 167 (823) 39 (−99 to 177) 0.579
  Emergency department attendance 56 (180) 77 (173) 21 (−8 to 51) 0.155
  Outpatient health professional service 492 (439) 486 (392) −4 (−66 to 51) 0.900
  STAT implementation costs 0 (0) 121 (91) 122 (112 to 131) <0.001
Between- group mean difference calculated using service as a covariate.
STAT, Specific Timely Appointments for Triage.
Figure 1 Confidence ellipses STAT versus traditional waitlist for the incremental health system cost ($A) (vertical axis) per day 
reduction in waiting time (horizontal axis). STAT, Specific Timely Appointments for Triage.
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Distributing costs over 12 months, the ICER shows a cost 
of $A4 (95% CI −25 to 32) per day of reduction in waiting 
time with STAT. The curve shows a 67% probability that 
the additional cost of STAT, compared with traditional 
waitlist, was at or below $A10 per day of waiting saved.
DISCUSSION
The findings from this study show a significant reduc-
tion in waiting time for community outpatient services 
following the introduction of the STAT model, at minimal 
cost to the health system. Modelling showed that the 
probability of STAT implementation approaching cost 
neutrality would increase over a 6- month and 12- month 
period post- implementation.
STAT, involving targeted investment coupled with 
a change in model of service delivery to address the 
underlying mechanisms that contribute to the develop-
ment of waiting lists, was cost- effective. Therefore, imple-
mentation of STAT is likely to result in a better use of 
resources than some alternatives. Previous research 
with much larger investments to tackle waiting lists by 
reducing backlogs has been ineffective.7 31 Kenis argued 
that attempts to combat waiting lists by simply adding 
resources to increase supply without changes to service 
delivery ignores the complexity of the problem.31
The reduction in waiting time, at minimal cost to the 
health system, supports previous findings that waiting 
times are not typically a result of lack of capacity, but 
related to suboptimal allocation of resources.32 Shorter 
waiting times have been shown to be associated with 
improved patient outcomes and may alleviate some of the 
anxiety patients experience while awaiting health inter-
ventions.9 12 Furthermore, clinicians report increased 
flexibility in their scheduling and a perception of a more 
efficient service when using the STAT model.9 33 There-
fore, in addition to its relatively low cost, STAT is a model 
that has the potential to improve patient outcomes and 
appears to be well accepted by clinicians.9 12
Although this study did not measure the return on 
investment from a societal perspective, it is possible that 
there are also benefits for the patients referred to the 
community outpatient services. For patients of working 
Figure 2 Cost- effectiveness acceptability curve STAT versus traditional waitlist for the probability of cost- effectiveness (vertical 
axis) versus a range of cost- effectiveness willingness to pay values ($A) per day reduction in waiting time (horizontal axis). STAT, 
Specific Timely Appointments for Triage.
Table 4 Mean total health system cost (SD) of health service in STAT and post and traditional waitlist periods and mean 
(95% CI) difference between groups ($A) and ICERs modelled at 6 and 12 months post- STAT implementation
Perspective
Groups Difference between groups
ICER*




6 months 1324 (2754) 1414 (2372) 93 (–334 to 519) 6.3 0.669
12 months 1324 (2755) 1390 (2369) 68 (–358 to 495) 4.4 0.753
Between- group mean difference calculated using service as a covariate.
*Cost per day of reduced waiting time.
.ICER, incremental cost- effectiveness ratio; STAT, Specific Timely Appointments for Triage.
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age, these benefits may include a reduction in loss of work 
income, as one of the benefits of reduction in waiting 
time for patients referred to community outpatient 
services includes decreasing work absenteeism.11 12 34 For 
children and older patients, these benefits may include 
a reduction in the costs associated with informal care. 
Earlier access to community- based therapy may facilitate 
a more rapid functional recovery (eg, rehabilitation of 
the underlying impairment) or introduce a compensa-
tion strategy (eg, prescription of walking aid) to enable 
earlier participation in the home, school or workplace 
and reduced dependence on others.35
In a UK study, Propper estimated the population will-
ingness to pay to avoid waiting for non- urgent outpatient 
treatment under the National Health Service.13 Their 
findings suggested a willingness to pay of £40 per month 
in 1987 (which equates to $183 per month in $A 2017, 
or $A6 per day).13 This is consistent with our result of 
$A4–$A6 per day saved in reduced waiting time suggesting 
that the cost of implementing STAT is likely to be within 
community expectations of the value of reduced waiting 
time.
In our study, participants in the STAT group were 
observed to have higher AQOL utility scores at admission 
to health service than participants in the traditional wait-
list group; a difference of 0.03 units that approached but 
did not reach significance. If a genuine difference exists, 
one interpretation of this finding is that difference in the 
baseline characteristics of groups is a limitation of the 
study. An alternative explanation is that observed reduc-
tions in health- related quality of life in participants in the 
traditional waitlist group were due to a deterioration in 
health status during the waiting period. Systematic reviews 
have demonstrated that patients experience significant 
declines in both physical and psychological health with 
longer wait times for health services.12 36 Clinicians identi-
fied that the main advantage of the STAT model was that 
patients could receive a healthcare intervention sooner 
which had positive impacts on their health outcomes.33 
Therefore, it is possible that patients in the STAT group 
may have been healthier at the time of admission because 
they had a shorter wait time for health service input. 
Consequently, it is difficult to predict the directional rela-
tionship between utility scores and healthcare costs.
Implementing STAT involves a one- off financial invest-
ment to reduce the waiting list, followed by the introduc-
tion of strategies to maintain patient flow at the rate of 
demand. Therefore, the return on investment of STAT 
should improve with time as more patients receive timely 
services. Our modelling showed that the cost per day of 
waiting saved reduced from $A9 3 months after STAT 
implementation to $A4 if the benefits are maintained at 
12 months. A 12- month follow- up, evaluation to the main 
trial showed that these benefits are mostly maintained 
with a 29% reduction in waiting time attributable to 
STAT over 12 months, compared with 34% in the original 
trial.37 However, results varied between services, possibly 
indicating that there were differences in compliance with 
STAT processes between services including ongoing esti-
mation of demand.37 The original trial was not powered 
to explore the differences between sites and this could be 
addressed in future research.
There was a large variation in the cost of implementing 
STAT at the eight participating services. These costs were 
influenced by the size of the residual waiting list, the 
degree of specialty (and subsequent cost of supply) of 
the services provided and the availability of professionals 
to support backlog reduction strategies. For example, 
several services were able to increase hours of existing 
staff to address the existing waiting list, but one that did 
not have this opportunity contracted private practitioners 
at much higher cost. Services involved in previous trials 
of STAT have been able to implement the model at no 
cost, by using strategies such as timing the introduction 
of the intervention to seasonal reductions in referral 
numbers.27 38 The implementation costs reported in 
this study represent the combined experience of eight 
separate sites and therefore provide policymakers with a 
broad indication of costs of implementation.
Findings from the main STAT trial suggest that STAT 
was most likely to benefit patients who waited the longest 
for an appointment.17 This means that those who waited 
the shortest to receive an appointment may have received 
little benefit from the STAT intervention. Weighted 
mean waiting time at the 10th percentile increased by 
1.1 days with STAT, although this first appointment was 
still within 10 days of referral. A limitation of our study is 
that we were unable to determine the impact of STAT on 
patients who would be categorised as ‘high’ need by clini-
cians using a triage approach under a traditional waitlist 
model. However, the STAT model incorporated systems 
for emergency appointments for patients with immediate 
clinical needs, ensuring that those with ‘high’ clinical 
needs could immediately access the service and were not 
disadvantaged. Also, in our main trial, STAT had no detri-
mental effects on outpatient care or outcomes, with no 
increase in the number of unplanned hospital readmis-
sions or decrease in the number of review appointments.17 
Therefore, it is unlikely that patients with a ‘high’ clinical 
need were disadvantaged by the STAT model.
A limitation of our study is that return on investment 
was not calculated from a societal perspective. Initially, 
we had planned to include patient outcomes (quality of 
life, cost of informal care, cost of employment hours lost). 
However, due to difficulties with patient follow- up, we 
were unable to obtain sufficient complete data for anal-
ysis in our study.16 We also had limited access to hospital 
administration data to determine the cost of emergency 
department presentations and hospital admissions. We 
therefore modelled the costs of these services based on 
assumptions from the information we had and publicly 
available hospital data sources. Using a pre–post design 
could increase the risk of bias in the results. However, 
this study was nested within a larger stepped- wedge 
randomised controlled trial and estimates of effect on 
reducing waiting time were similar to those observed in 
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the larger trial.17 Also, the relatively large sample size and 
demonstration of baseline equivalence for key factors 
increase confidence in our results. The apparent discrep-
ancy between overall cost of STAT implementation 
($A105 per patient) and cost within this study ($A121 per 
patient) was due to variations in the proportion of partici-
pants included in each site in the two studies. Participants 
were not told whether they were attending the service 
within the pre- period or post- period. This blinding of 
participants is a strength of this study as it reduces the 
potential influence of bias. Another strength is the diver-
sity of clinical services that the eight participating sites 
provided. This increases the generalisability of our find-
ings to other public health networks.
CONCLUSIONS
STAT significantly reduced waiting times for patients 
referred to public community outpatient services at 
minimal cost to the health system. Modelling showed that 
the probability of STAT being cost neutral increased over 
a 6- month and 12- month period post- implementation. 
These results support the implementation of STAT across 
a variety of community outpatient services as a cost- 
effective way to reduce patient waiting time by matching 
capacity with demand.
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